Characteristics of the mRNA datasets in DoSurvive.


Number of Patients tested with mRNA.

Cancer Types Patients (OS) Patients (DSS) Patients (DFI) Patients (PFI) Gene (OS)
Adrenocortical carcinoma (ACC) 79 77 45 79 16146
Bladder Urothelial Carcinoma (BLCA) 407 393 187 408 16574
Breast invasive carcinoma (BRCA) 1092 1073 948 1092 16730
Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) 304 300 174 304 16472
Cholangiocarcinoma (CHOL) 36 35 24 36 16709
Colon adenocarcinoma (COAD) 298 282 109 298 16589
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (DLBC) 48 48 28 48 16058
Esophageal carcinoma (ESCA) 184 182 88 184 16966
Glioblastoma multiforme (GBM) 159 147 1 159 16955
Head and Neck squamous cell carcinoma (HNSC) 520 494 131 520 16788
Kidney Chromophobe (KICH) 65 65 29 65 16434
Kidney renal clear cell carcinoma (KIRC) 533 522 117 531 16727
Kidney renal papillary cell carcinoma (KIRP) 289 285 183 288 16587
Acute Myeloid Leukemia (LAML) 161 0 0 0 15784
Brain Lower Grade Glioma (LGG) 514 506 133 514 16848
Liver hepatocellular carcinoma (LIHC) 370 362 316 370 16225
Lung adenocarcinoma (LUAD) 507 472 302 507 16920
Lung squamous cell carcinoma (LUSC) 495 443 300 496 17068
Mesothelioma (MESO) 86 66 15 84 16665
Ovarian serous cystadenocarcinoma (OV) 303 279 146 303 17004
Pancreatic adenocarcinoma (PAAD) 178 172 69 178 17313
Pheochromocytoma and Paraganglioma (PCPG) 179 179 160 179 16524
Prostate adenocarcinoma (PRAD) 497 495 337 497 16838
Rectum adenocarcinoma (READ) 97 91 30 97 16646
Sarcoma (SARC) 259 253 152 259 16448
Skin Cutaneous Melanoma (SKCM) 454 448 0 455 16166
Stomach adenocarcinoma (STAD) 412 389 241 414 17047
Testicular Germ Cell Tumors (TGCT) 134 134 105 134 17628
Thyroid carcinoma (THCA) 501 495 352 501 16510
Thymoma (THYM) 119 119 0 119 16747
Uterine Corpus Endometrial Carcinoma (UCEC) 182 180 119 182 16802
Uterine Carcinosarcoma (UCS) 57 55 27 57 17156
Uveal Melanoma (UVM) 80 80 0 79 15770
*OS: Overall survival, DSS: Disease-specific survival, DFI: Disease-free survival, PFI: Progression-free survival